ALBEMARLE CORP Quarterly Cost of Revenue in USD from Q3 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Albemarle Corp quarterly/annual Cost of Revenue history and growth rate from Q3 2017 to Q4 2024.
  • Albemarle Corp Cost of Revenue for the quarter ending December 31, 2024 was $1.09B, a 64.3% decline year-over-year.
  • Albemarle Corp Cost of Revenue for the twelve months ending December 31, 2024 was $5.31B, a 37% decline year-over-year.
  • Albemarle Corp annual Cost of Revenue for 2024 was $5.31B, a 37% decline from 2023.
  • Albemarle Corp annual Cost of Revenue for 2023 was $8.43B, a 98.6% increase from 2022.
  • Albemarle Corp annual Cost of Revenue for 2022 was $4.25B, a 82.2% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $5.31B $1.09B -$1.97B -64.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-12
Q3 2024 $7.28B $1.46B -$797M -35.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $8.08B $1.44B -$371M -20.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $8.45B $1.32B +$18.1M +1.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $8.43B $3.06B +$1.44B +88.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-12
Q3 2023 $6.99B $2.26B +$1.21B +115% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $5.78B $1.81B +$913M +101% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $4.87B $1.3B +$625M +92.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $4.25B $1.62B +$962M +146% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-12
Q3 2022 $3.28B $1.05B +$467M +80.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $2.82B $899M +$374M +71.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.44B $679M +$113M +20% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.33B $658M +$43.9M +7.15% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $2.29B $581M +$88.5M +18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.2B $525M -$5.21M -0.98% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.2B $566M +$68.8M +13.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.13B $614M -$40.3M -6.17% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $2.17B $493M -$77.1M -13.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.25B $531M -$28.4M -5.09% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $2.28B $497M -$51.8M -9.43% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $2.33B $654M +$52.7M +8.77% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $2.28B $570M +$72.7M +14.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $2.21B $559M +$16.6M +3.06% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $2.19B $549M +$31.9M +6.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $2.16B $601M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $497M +$18M +3.76% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $543M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $517M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 $479M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.